http://www.crinetics.com
Crinetics Pharmaceuticals, Inc. Company Intro
About: Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We have assembled a seasoned team with extensive expertise in drug discovery and development in endocrine G-protein coupled receptors (GPCRs) and built a highly productive drug discovery organization.
Industry
Healthcare
Crinetics Pharmaceuticals, Inc. Headquaters
Building No. 2
San Diego,92121
United States
Crinetics Pharmaceuticals, Inc. Share price
17 May 2023 13:01 GMT
$21.88
-0.45 (-2.02 %)
Crinetics Pharmaceuticals, Inc. Market cap
$1.195 B
WMC RANKING
2024
Crinetics Pharmaceuticals, Inc. # 286
BiotechnologyLatest Crinetics Pharmaceuticals, Inc. News
12 Feb 2024
Victory Capital Management Inc. Makes New Investment in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Read Victory Capital Management Inc. Makes New Investment in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) at Defense World.
12 Feb 2024
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Bought by Principal Financial Group Inc.
Read Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Bought by Principal Financial Group Inc. at Defense World.
12 Feb 2024
Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2024, the Compensation...
WMC Market Score
WMC Market to Revenue Score
Crinetics Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Crinetics Pharmaceuticals, Inc. | USD | $0 | $80,089 | $-79,353 | $11,950B | 286 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Crinetics Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Crinetics Pharmaceuticals, Inc. | 0.01 | 2.21 | 0.06 | 0 | 0 | 0 | 0.81 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
